These findings indicate that up-regulating specific miRNAs or inhibiting NUSAP1 expression to target the miRNA/NUSAP1 pathway may represent a promising therapeutic strategy for digestive system tumors (Table 3). This evidence concerns the gene NUSAP1 and digestive system neoplasm.